President and CEO and EVP
The Board of Directors appoints and dismisses the President and CEO of Oriola-KD.
The President and CEO is in charge of the day-to-day management of the company and its administration in accordance with the Finnish Companies Act and the instructions and orders of the Board of Directors. The President and CEO also ensures that accounts of the company comply with Finnish law and that its financial affairs have been organised in a reliable manner. The President and CEO is assisted in his work by the Group Management Team. The President and CEO’s service terms and conditions are specified in writing in the President and CEO’s service contract, which is approved by the Board of Directors.
The President and CEO of the company is Mr Eero Hautaniemi, M.Sc. (Econ.), born in 1966.
Mr. Hautaniemi has been President and CEO of Oriola-KD Corporation since the establishment in 2006. Mr Hautaniemi served as President of GE Healthcare Finland Oy during 2004–2005, and as General Manager and Vice President of Oximetry, Supplies and Accessories business area of GE Healthcare IT in 2003–2004. Before this Mr. Hautaniemi held different positions in financial and business management in Instrumentarium Corporation in Finland and in the United States.
Mr. Hautaniemi is a member of the Board of Directors of Lassila & Tikanoja Corporation, Ecostream Oy and Finnish-Russian Chamber of Commerce. He is also a member of the GIRP Management Board and GIRP Treasurer (GIRP= The European Association of Pharmaceutical Full-line Wholesalers).
When necessary, the Board of Directors also appoints an Executive Vice President. The company's Executive Vice President and deputy to the President and CEO is Mr Kimmo Virtanen, Executive Vice President of Oriola-KD's Pharmaceutical Wholesale businesses in Finland, Sweden and the Baltic Countries and Managing Director of Oriola Oy, M.Sc. (Econ.), born in 1968.
Further information on remuneration and terms of service of the President and CEO of Oriola-KD can be found in the Remuneration Statement and in the Annual Report.